clorexolone

Suppliers

Names

[ CAS No. ]:
2127-01-7

[ Name ]:
clorexolone

[Synonym ]:
Clorexolonum [INN-Latin]
6-chloro-2-cyclohexyl-3-oxo-1,3-dihydro-isoindole-5-sulfonic acid amide
Flonatril
Clorexolona [INN-Spanish]
clorexolone
Klorex
Chlorexolone
Cloresolone [DCIT]
Nefrolan
Clorexolon

Chemical & Physical Properties

[ Density]:
1.447g/cm3

[ Boiling Point ]:
577.2ºC at 760mmHg

[ Molecular Formula ]:
C14H17ClN2O3S

[ Molecular Weight ]:
328.81400

[ Flash Point ]:
302.9ºC

[ Exact Mass ]:
328.06500

[ PSA ]:
88.85000

[ LogP ]:
3.99490

[ Vapour Pressure ]:
2.54E-13mmHg at 25°C

[ Index of Refraction ]:
1.631

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NR3538000
CHEMICAL NAME :
5-Isoindolinesulfonamide, 6-chloro-2-cyclohexyl-3-oxo-
CAS REGISTRY NUMBER :
2127-01-7
BEILSTEIN REFERENCE NO. :
0493411
LAST UPDATED :
199612
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C14-H17-Cl-N2-O3-S
MOLECULAR WEIGHT :
328.84

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
6 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YAKUD5 Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959- Volume(issue)/page/year: 21,775,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
120 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JPPMAB Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- Volume(issue)/page/year: 18,65,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>6 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,257,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
560 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
BFPHA8 Bulletin of the Faculty of Pharmacy (Cairo University). (Faculty of Pharmacy, Cairo Univ., Cairo, Egypt) V.1- 1961/62- Volume(issue)/page/year: 10,155,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
230 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JPPMAB Journal of Pharmacy and Pharmacology. (Pharmaceutical Soc. of Great Britain, 1 Lambeth High St., London SEI 7JN, UK) V.1- 1949- Volume(issue)/page/year: 18,65,1966

Safety Information

[ HS Code ]:
2935009090

Customs

[ HS Code ]: 2935009090

[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%


Related Compounds

  • 2-Bromo-4-(difluoromethyl)-6-iodopyridin-3-ol
  • 2-Chloro-6-(difluoromethyl)-5-methylnicotinonitrile
  • 2-Chloro-3-(difluoromethyl)-6-methoxy-4-(trifluoromethyl)pyridine
  • 6-(Difluoromethyl)-5-methyl-3-(trifluoromethyl)pyridin-2-amine
  • (2-Bromo-5-(difluoromethyl)-6-fluoropyridin-3-yl)methanol
  • 2-(2-Bromo-6-(chloromethyl)-3-(difluoromethyl)pyridin-4-yl)acetonitrile
  • (2-Amino-5-(difluoromethyl)-6-methoxypyridin-3-yl)methanol
  • 4-Chloro-3-(difluoromethyl)-5-nitropyridin-2-amine
  • 2-Bromo-6-hydroxy-5-(trifluoromethoxy)nicotinonitrile
  • 3-(Difluoromethyl)-6-methyl-4-nitropicolinonitrile
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.